Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer
<p>Abstract</p> <p>Background</p> <p>The CyberKnife is an appealing delivery system for hypofractionated stereotactic body radiation therapy (SBRT) because of its ability to deliver highly conformal radiation therapy to moving targets. This conformity is achieved via 10...
Main Authors: | Pahira John, Bandi Gaurav, Dejter Stephen W, Constantinople Nicholas L, Batipps Gerald P, Chen Viola J, Borum Devin, Sherer Benjamin A, Piel Nathaniel, Rohan JoyAnn P, Ennis Brook, Zhang Guowei, Yu Xia, Lei Sue, Kim Joy S, Hanscom Heather N, Suy Simeng, Oermann Eric K, McGeagh Kevin G, Adams-Campbell Lucile, Jha Reena, Dawson Nancy A, Collins Brian T, Dritschilo Anatoly, Lynch John H, Collins Sean P |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-03-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | http://www.jhoonline.org/content/4/1/12 |
Similar Items
-
Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer
by: Chiranjeev eDash, et al.
Published: (2012-10-01) -
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
by: Ju Andrew W, et al.
Published: (2013-01-01) -
Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by: Maria Antonia Gómez-Aparicio, et al.
Published: (2021-08-01) -
The Prostate Clinical Outlook (PCO) Classifier Application for Predicting Biochemical Recurrences in Patients Treated by Stereotactic Body Radiation Therapy (SBRT)
by: Seong K. Mun, et al.
Published: (2018-09-01) -
Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation
by: Michael C. Repka, et al.
Published: (2017-10-01)